Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 901 to 950 of 2013

TitleReference numberPublishedLast updated
Peginterferon beta-1a for treating relapsing–remitting multiple sclerosisTA624
Patiromer for treating hyperkalaemiaTA623
Antenatal and postnatal mental health: clinical management and service guidanceCG192
Leg ulcer infection: antimicrobial prescribingNG152
Episcissors-60 for mediolateral episiotomyHTG538
Fetoscopic prenatal repair for open neural tube defects in the fetusHTG536
Open prenatal repair for open neural tube defects in the fetusHTG537
Supporting adult carersNG150
Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissuesHTG535
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and CHTG385
Atezolizumab with carboplatin and nab-paclitaxel for untreated advanced non-squamous non-small-cell lung cancer (terminated appraisal)TA618
Indoor air quality at homeNG149
Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedureTA617
Cannabidiol with clobazam for treating seizures associated with Dravet syndromeTA614
Cannabidiol with clobazam for treating seizures associated with Lennox–Gastaut syndromeTA615
Balloon dilation for chronic eustachian tube dysfunctionHTG534
gammaCore for cluster headacheHTG533
Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2HST12
Diverticular disease: diagnosis and managementNG147
Irreversible electroporation for primary liver cancerHTG532
Workplace health: long-term sickness absence and capability to workNG146
Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumabTA612
Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrastHTG530
Rapid tests for group A streptococcal infections in people with a sore throatHTG531
Pentosan polysulfate sodium for treating bladder pain syndromeTA610
Ibrutinib with rituximab for treating Waldenstrom's macroglobulinaemia (terminated appraisal)TA608
Ramucirumab for treating unresectable hepatocellular carcinoma after sorafenib (terminated appraisal)TA609
Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and managementCG184
Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery diseaseTA607
End of life care for adults: service deliveryNG142
Lanadelumab for preventing recurrent attacks of hereditary angioedemaTA606
Midcarpal hemiarthroplasty for wrist arthritisHTG529
Diabetic foot problems: prevention and managementNG19
Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutationsHST11
Gastro-oesophageal reflux disease in children and young people: diagnosis and managementNG1
Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoeaTA605
EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healingHTG296
Familial hypercholesterolaemia: identification and managementCG71
Idelalisib for treating refractory follicular lymphomaTA604
Cellulitis and erysipelas: antimicrobial prescribingNG141
Pomalidomide with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA602
Lenalidomide with bortezomib and dexamethasone for untreated multiple myeloma (terminated appraisal)TA603
High-intensity focused ultrasound for glaucomaHTG527
Bioprosthetic plug insertion for anal fistulaHTG528
Tegaderm CHG securement dressing for vascular access sites in critically ill adultsHTG379
Attention deficit hyperactivity disorder: diagnosis and managementNG87
Implant insertion for prominent earsHTG526
Benralizumab for treating severe eosinophilic asthmaTA565
Risankizumab for treating moderate to severe plaque psoriasisTA596
Patisiran for treating hereditary transthyretin amyloidosisHST10

Results per page

  1. 10
  2. 25
  3. 50
  4. All